采用国际TILs工作组系统评估的肿瘤浸润淋巴细胞在甲状腺髓样癌中无预后价值
这项回顾性队列研究纳入1995至2016年在澳大利亚悉尼皇家北岸医院手术治疗的71例原发性甲状腺髓样癌患者,采用国际TILs工作组系统评估肿瘤浸润淋巴细胞并与临床病理预后变量及生存结局相关分析。结果显示所有患者TILs均低,中位3%(范围0-10%);Cox回归中TILs增加与局部复发风险升高(log-rank p=0.022,OR 1.94,95%CI 0.61-6.16,p=0.26)和疾病特异性生存降低(log-rank p=0.015,OR 5.11,95%CI 1.01-26.0,p=0.049)相关,多变量分析中无显著关联。结论认为TILs在甲状腺髓样癌中预后价值有限。
要点
- 所有甲状腺髓样癌患者TILs均低,中位3%(范围0-10%)。
- 仅高IMTCGS分级与TILs增加显著相关(OR 7.29,95%CI 1.21-43.90,p=0.015)。
- 多变量分析中TILs与局部复发或疾病特异性生存无显著关联。
核心结论
- 在本研究中,TILs在甲状腺髓样癌中的预后价值有限。
- 即使高级别甲状腺髓样癌也可被视为免疫静止肿瘤,与更高分级肿瘤相关的不良预后因素超过TILs轻微增加带来的免疫识别边缘性增加。
- 甲状腺髓样癌中TILs水平低且与生存缺乏相关性,提示免疫检查点抑制剂治疗可能无效。
研究设计与样本
- 回顾性队列研究,纳入1995至2016年在澳大利亚悉尼皇家北岸医院手术治疗的71例原发性甲状腺髓样癌患者。
- 采用国际TILs工作组系统评估原发甲状腺髓样癌肿瘤的TILs谱,并与临床病理预后变量(包括国际甲状腺髓样癌分级系统IMTCGS分级)及生存结局进行相关分析。
- 中位随访时间69个月(四分位距90个月)。
主要发现
- 所有甲状腺髓样癌患者TILs均低,中位3%(范围0-10%),进一步分为“极低”(0-4%)和“低”(5-10%)两组。
- Cox回归分析中,TILs增加与局部复发增加相关(log-rank p=0.022,OR 1.94,95%CI 0.61-6.16,p=0.26)。
- TILs增加与疾病特异性生存降低相关(log-rank p=0.015,OR 5.11,95%CI 1.01-26.0,p=0.049)。
- TILs增加与无远处转移生存降低呈趋势(log-rank p=0.14)。
- 仅“高IMTCGS分级”与TILs增加显著相关(OR 7.29,95%CI 1.21-43.90,p=0.015)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Tumor-infiltrating lymphocytes (TILs) are a protective prognostic factor in several solid tumors and predict response to immune checkpoint inhibitor therapy. The prognostic impact of TILs in medullary thyroid cancer (MTC) is poorly understood. Materials and Methods: In this retrospective cohort study, we assessed the TILs profile of primary MTC tumors using the International TILs Working Group system and correlated this with clinicopathological prognostic variables, including the International Medullary Thyroid Cancer Grading System (IMTCGS) grade and survival outcomes. Results: We identified 71 patients with primary MTC tumors who were treated surgically between 1995 and 2016 at the Royal North Shore Hospital in Sydney, Australia. The median (interquartile range) duration of follow-up was 69 (90) months. Using the ITWG system, all patients with MTC had low TILs, with a median (range) of 3% (0-10%). This group was further subdivided into "very low" (0-4%) and "low" (5-10%), and on Cox regression analysis, increasing TILs were associated with increased local recurrence (log-rank p = 0.022, odds ratio [OR] 1.94 [confidence interval or CI 0.61-6.16], p = 0.26), reduced disease-specific survival (log-rank p = 0.015, OR 5.11 [CI 1.01-26.0], p = 0.049), and a trend to decreased distant metastasis-free survival (log-rank p = 0.14). When examining the association between TILs and other prognostic factors, only "high IMTCGS grade" was significantly associated with increased TILs (OR 7.29 [CI 1.21-43.90], p = 0.015). In the multivariable logistic regression analysis, there was no significant association between TILs and local recurrence or disease-specific survival. Conclusions: In our study, the prognostic value of TILs in MTC was limited. Even high-grade MTC can be considered an immune quiescent tumor, and the adverse prognostic factors associated with higher grade tumors outweigh the marginal increase in immune recognition associated with a slight increase in TILs. The low level of TILs in MTC and their lack of correlation with survival suggest that immune checkpoint inhibitor therapy may not be effective.
引用
- Papachristos A, Zhou L, Sheen A, et al. Tumor-Infiltrating Lymphocytes Assessed Using the International TILs Working Group System Are Not Prognostic in Medullary Thyroid Cancer. Thyroid. 2025. PMID: 39868721. doi:10.1089/thy.2024.0595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。